BR112014026439A2 - comprimidos revestidos e produção dos mesmos - Google Patents

comprimidos revestidos e produção dos mesmos

Info

Publication number
BR112014026439A2
BR112014026439A2 BR112014026439A BR112014026439A BR112014026439A2 BR 112014026439 A2 BR112014026439 A2 BR 112014026439A2 BR 112014026439 A BR112014026439 A BR 112014026439A BR 112014026439 A BR112014026439 A BR 112014026439A BR 112014026439 A2 BR112014026439 A2 BR 112014026439A2
Authority
BR
Brazil
Prior art keywords
production
coated tablets
present
coated tablet
coated
Prior art date
Application number
BR112014026439A
Other languages
English (en)
Other versions
BR112014026439B1 (pt
Inventor
Lubda Dieter
Leonhard Ohrem Hans
Mechthild Breidung Melanie
Ognibene Roberto
Erika Bernhardt Sandra
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48045412&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014026439(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR112014026439A2 publication Critical patent/BR112014026439A2/pt
Publication of BR112014026439B1 publication Critical patent/BR112014026439B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

resumo patente de invenção: "comprimidos revestidos e produção dos mesmos". a presente invenção refere-se a uma formulação farmacêutica que se desintegra rapidamente na forma de um comprimido revestido que tem sua força mecânica ou dureza aumentada. a presente invenção, além disso, refere-se a um processo para a produção do comprimido revestido e à utilização destas formulações. 22564320v1 1/1 22564320v1
BR112014026439-2A 2012-04-27 2013-04-02 Formulação farmacêutica sob a forma de um comprimido revestido, e seu processo de preparação BR112014026439B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12002988.9 2012-04-27
EP12002988 2012-04-27
EP12006370 2012-09-11
EP12006370.6 2012-09-11
PCT/EP2013/000971 WO2013159861A1 (de) 2012-04-27 2013-04-02 Tabletten mit überzug und deren herstellung

Publications (2)

Publication Number Publication Date
BR112014026439A2 true BR112014026439A2 (pt) 2017-06-27
BR112014026439B1 BR112014026439B1 (pt) 2022-05-31

Family

ID=48045412

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014026439-2A BR112014026439B1 (pt) 2012-04-27 2013-04-02 Formulação farmacêutica sob a forma de um comprimido revestido, e seu processo de preparação

Country Status (13)

Country Link
US (1) US20150104512A1 (pt)
EP (1) EP2844234B1 (pt)
JP (2) JP6363993B2 (pt)
KR (1) KR102092002B1 (pt)
CN (1) CN104244931A (pt)
BR (1) BR112014026439B1 (pt)
CA (1) CA2871703C (pt)
CL (1) CL2014002896A1 (pt)
ES (1) ES2784134T3 (pt)
IL (1) IL234998B (pt)
MX (1) MX369549B (pt)
TW (2) TW201811316A (pt)
WO (1) WO2013159861A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
WO2017065623A1 (en) * 2015-10-16 2017-04-20 Mendoza Wendell Stable composition of vitamin c and zinc tablet
AU2017232554B2 (en) * 2016-03-16 2020-05-14 Golden Omega Norway As Powders and tablets comprising omega-3 fatty acid derivatives and methods for their production
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP2018184375A (ja) * 2017-04-27 2018-11-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法
JP7202898B2 (ja) * 2018-01-11 2023-01-12 沢井製薬株式会社 フィルムコーティングされた口腔内崩壊錠
CN118340736B (zh) * 2024-04-23 2024-10-18 海南恒诚三叶制药有限公司 头孢泊肟酯片及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ534340A (en) * 2002-02-07 2006-04-28 Pharmacia Corp Pharmaceutical dosage form for mucosal delivery
CN101888833A (zh) * 2004-07-26 2010-11-17 特瓦制药工业有限公司 包含肠溶衣包被的芯片的剂型
MX2007001058A (es) * 2004-07-26 2007-04-16 Teva Pharma Formas de dosificacion con tableta nucleo recubierta entericamente.
BRPI0709909A2 (pt) * 2006-03-31 2011-07-26 Rubicon Res Private Ltd tabletes de desintegraÇço oral
ES2416072T3 (es) 2006-09-15 2013-07-30 Capsugel Belgium Nv Forma de dosificación de disgregación rápida
JP5289975B2 (ja) * 2006-12-07 2013-09-11 第一三共株式会社 マンニトール又は乳糖を含有する固形製剤
PL2209501T3 (pl) * 2007-10-12 2012-03-30 Astrazeneca Ab Kompozycja zibotentanu zawierająca mannitol i celulozę mikrokrystaliczną
WO2009135646A2 (en) * 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
CA2728436C (en) * 2008-06-20 2016-07-26 Merck Patent Gmbh Directly compressible and rapidly disintegrating tablet matrix
KR101921934B1 (ko) * 2009-02-13 2018-11-26 베링거 인겔하임 인터내셔날 게엠베하 글루코피라노실 디페닐메탄 유도체를 포함하는 약제학적 조성물, 이들의 약제학적 용량형, 이들의 제조방법 및 환자에서의 개선된 당 조절을 위한 이들의 용도
TWI455733B (zh) * 2009-03-30 2014-10-11 Toray Industries 口腔內崩壞性被覆錠劑
SG10201407947WA (en) 2009-11-30 2015-01-29 Aptalis Pharmatech Inc Compressible-coated pharmaceutical compositions and tablets and methods of manufacture
CN104159583B (zh) * 2012-02-22 2018-04-13 富山化学工业株式会社 含有1‑(3‑(2‑(1‑苯并噻吩‑5‑基)乙氧基)丙基)氮杂环丁烷‑3‑醇或其盐的固体药物组合物

Also Published As

Publication number Publication date
IL234998A0 (en) 2014-12-31
TW201811316A (zh) 2018-04-01
EP2844234B1 (de) 2020-01-08
EP2844234A1 (de) 2015-03-11
ES2784134T3 (es) 2020-09-22
CN104244931A (zh) 2014-12-24
MX2014012799A (es) 2015-01-22
CA2871703A1 (en) 2013-10-31
CA2871703C (en) 2021-03-30
IL234998B (en) 2019-07-31
KR102092002B1 (ko) 2020-03-23
BR112014026439B1 (pt) 2022-05-31
JP2017193585A (ja) 2017-10-26
US20150104512A1 (en) 2015-04-16
JP6363993B2 (ja) 2018-07-25
MX369549B (es) 2019-11-12
WO2013159861A1 (de) 2013-10-31
TW201410268A (zh) 2014-03-16
JP2015514786A (ja) 2015-05-21
CL2014002896A1 (es) 2014-12-19
KR20150003891A (ko) 2015-01-09
TWI697341B (zh) 2020-07-01

Similar Documents

Publication Publication Date Title
BR112014026439A2 (pt) comprimidos revestidos e produção dos mesmos
DOP2017000105A (es) Métodos y productos de fármaco para tratar enfermedad de alzheimer
BR112014018378A8 (pt) Processo contínuo para a preparação de um comprimido compreendendo ácido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol5-il) ciclopropanocarboxamido)-3-metilpiridin-2-il)benzoico
BR112015011403A2 (pt) uso de akkermansia para o tratamento de distúrbios metabólicos
BR112015000150A2 (pt) composições farmacêuticas dissuasoras de abuso de liberação controlada
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
PH12015500587A1 (en) Combination of regorafenib and acetylsalicylic acid for treating cancer
BR112015007365A2 (pt) Processo para a preparação de um hidrogel, pró-droga ligada a um suporte e composição farmacêutica
IN2014DN06501A (pt)
NZ702977A (en) 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
BR112014010708A2 (pt) pró-fármaco à base de polietilenoglicol de adrenomedulina e utilização do mesmo
BR112015011430A2 (pt) composição para liberação imediata e prolongada
BR112014002025A2 (pt) partículas que compreendem compostos ativos com base em poliacrilato
BR112015014158A2 (pt) poloxâmeros de cadeia prolongada, hidrogéis termor-reversíveis formados a partir dos mesmos com mate-riais biológicos e aplicações médicas dos mesmos
GT201400288A (es) "compuestos de fenoxietil piperidina"
CL2008000738A1 (es) Compuestos derivados de malonamida; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la depresion, enfermedad de parkinson y alzheimer, entre otras enfermeda
MY156302A (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ß-AMYLOID DISEASES AND SYNUCLEINOPATHIES
BR112015001521A2 (pt) previsão de resposta ao tratamento para inibidor jak/stat
BR112015000443A2 (pt) derivados de estra-1,3,5(10),16-tetraeno 3-substituídos, processo para a sua produção, preparações farmacêuticas que contêm os mesmos, bem como seu uso para a produção de medicamentos
BR112015030431A2 (pt) formulação de liberação modificada
BR112015014137A2 (pt) unidade sólida com alto teor de fexofenadina e processo para a preparação da mesma
BR112014025972A8 (pt) monocloridratos de anamorelina, composições, processo para preparar monocloridrato de anamorelina, método para produzir uma forma de dosagem farmacêutica e forma de dosagem farmacêutica oral
BR112013029416A2 (pt) derivados de indol substituídos para o tratamento de distúrbios imunológicos
BR112013005226A2 (pt) "n-fenetiltriazolonaacetamidas substituídas e o seu uso".
BR112016007031A8 (pt) composição farmacêutica oral sólida, processo para preparar a composição farmacêutica oral sólida, e uso de uma composição farcêutica oral sólida

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/04/2013, OBSERVADAS AS CONDICOES LEGAIS